BSE - Delayed Quote INR

Syncom Formulations (India) Limited (SYNCOMF.BO)

Compare
18.11
-0.78
(-4.13%)
At close: January 10 at 3:58:59 PM GMT+5:30

Key Executives

Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in INR.
NameTitlePayExercisedYear Born
Mr. Kedarmal Shankarlal Bankda M.Com Executive Chairman & Whole- Time Director 7.36M -- 1952
Mr. Vijay Shankarlal Bankda B. Com LLB MD and Executive & Non Independent Director 8.66M -- 1958
Mr. Ankit Kedarmal Bankda CFO & Compliance Officer -- -- 1987
Ms. Vaishali Agrawal Company Secretary & Compliance Officer -- -- --
Mr. Rakesh Ch. Srivastava Chief Marketing Officer -- -- 1962
Ms. Payal Ankur Bankda Vice President of Human Resources -- -- 1987
Ms. Rinki Ankit Bankda Whole Time Director 3.02M -- 1987
Mr. Ankur Vijay Bankda President of Export Marketing -- -- 1985
Mr. Rahul Vijay Bankda President of Domestic Marketing -- -- 1980

Syncom Formulations (India) Limited

Syncom House
207, Saket Nagar Near Saket Club
Indore, 452018
India
91 73 1270 0458 https://www.syncomformulations.com
Sector: 
Healthcare
Full Time Employees: 
998

Description

Syncom Formulations (India) Limited manufactures, markets, and sells pharmaceutical formulation products in India. It operates through Manufacturing and Dealing in Pharmaceutical Drug & Formulations, Trading of Commodities, and Renting of Properties segments. The company offers antibiotics/antiinfectives, anthelmintics, antimalarial, cardiac, derma, gastro, gynae, opthal, ortho, and pediatrics formulations. It provides life care, evolve, and right nutrition products under the Cratus brand. In addition, the company engages in the trading of commodities and renting of properties. It also exports its products. The company offers its pharmaceutical formulations products in various dosage forms, such as tablets, capsules, ointments, injections, liquids orals, and effervescent. Syncom Formulations (India) Limited was incorporated in 1988 and is based in Indore, India.

Corporate Governance

Syncom Formulations (India) Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

February 12, 2025 at 5:30 AM UTC - February 17, 2025 at 5:30 AM UTC

Syncom Formulations (India) Limited Earnings Date

Recent Events

September 9, 2022 at 12:00 AM UTC

Ex-Dividend Date

Related Tickers

JENBURPH.BO Jenburkt Pharmaceuticals Limited
1,275.00
+3.82%
 
THEMISMED.NS Themis Medicare Limited
260.00
-4.15%
 
GLAND.BO Gland Pharma Limited
1,778.75
-2.66%
 
MOREPENLAB.NS Morepen Laboratories Limited
68.84
-2.89%
 
NATCOPHARM.NS NATCO Pharma Limited
1,235.05
-4.13%
 
DRREDDY.NS Dr. Reddy's Laboratories Limited
1,357.60
-1.02%